Table 3.
Term | Effect | Coefficient | T | p-value |
---|---|---|---|---|
Constant | 762,938 | 146.00 | 0.000 | |
A | − 23,625 | − 11,812 | − 2.27 | 0.151 |
B | − 12,375 | − 6187 | − 1.19 | 0.356 |
C | − 75,375 | − 37,687 | − 7.24 | 0.019 |
D | − 78,625 | − 39,313 | − 7.55 | 0.017 |
E | 6375 | 3188 | 0.61 | 0.603 |
F | 72,375 | 36,187 | 6.95 | 0.020 |
AB | − 53,875 | − 26,938 | − 5.18 | 0.035 |
AC | 32,125 | 16,062 | 3.09 | 0.091 |
AD | 8875 | 4437 | 0.85 | 0.484 |
AE | − 95,125 | − 47,563 | − 9.14 | 0.012 |
AF | 10,875 | 5437 | 1.04 | 0.406 |
BD | 25,125 | 12,563 | 2.41 | 0.137 |
BF | 48,125 | 24,063 | 4.62 | 0.044 |
ABD | − 15,375 | − 7688 | − 1.48 | 0.278 |
ABF | − 59,375 | − 29,687 | − 5.70 | 0.029 |
Center point | – | 57,604 | − 4.40 | 0.048 |
S = 20,816.7, R2 = 99.46%, R2 (adjusted) = 95.13%, Significant at p-value < 0.05. A (Bacto™ soytone), B (Bacto™ yeast extract), C (vitamin C); D (vitamin B12), E (SITE liquid media supplement), and F (recombinant human epidermal growth factor, rEGF) were the factors (serum substitutes) used in a 26–2 fractional factorial design